Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment.
Wang M, Vulcano S, Xu C, Xie R, Peng W, Wang J, Liu Q, Jia L, Li Z, Li Y.
Wang M, et al. Among authors: li y, li z.
J Pharm Anal. 2024 Mar;14(3):308-320. doi: 10.1016/j.jpha.2023.10.001. Epub 2023 Oct 13.
J Pharm Anal. 2024.
PMID: 38618250
Free PMC article.
Review.